1. Jiajing Tang, Qiantao Wang, Qianwen Yu, Yue Qiu, Ling Mei, Dandan Wan, Xuhui Wang, Man Li, Qin He*. A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma targeted drug delivery. Acta Biomaterialia, 2019, 83, 1, 379-389. IF=6.638
2. Qianwen Yu, Yue Qiu, Xiaoxiao Chen, Xuhui Wang, Ling Mei, Haiyao Wu, Kai Liu, Yayuan Liu, Man Li, Zhirong Zhang, Qin He*. Chemotherapy priming of the Pancreatic Tumor Microenvironment Promotes Delivery and Anti- Metastasis Efficacy of Intravenous Low-Molecular-Weight Heparin-Coated Lipid-siRNA Complex. Theranostics, 2019, 9, 2, 355-368. IF= 8.063
3. Chunyu Xia, Sheng Yin, Shanshan Xu, Guangyao Ran, Miao Deng, Ling Mei, Xian Tang, Jingdong Rao, Man Li, Zhirong Zhang, Qin He*. Low Molecular Weight Heparin-Coated and Dendrimer-Based Core-Shell Nanoplatform with Enhanced Immune Activation and Multiple Anti-Metastatic Effects for Melanoma Treatment. Theranostics, 2019, 9, 2, 337-354. IF=8.063
4. Xian Tang, Jingdong Rao, Sheng Yin, Jiaojie Wei, Chunyu Xia, Man Li, Ling Mei, Zhirong Zhang, Qin He*. PD-L1 knockdown via hybrid micelle promotes paclitaxel induced Cancer Immunity Cycle for melanoma treatment. European Journal of Pharmaceutical Sciences, 2019, 127, 15, 161-174. IF=3.532
5. Man Li, Yuting Yang, Chaoqun Xu, Jiaojie Wei, Yingke Liu, Xingli Cun, Qianwen Yu, Xian Tang, Sheng Yin, Zhirong Zhang, and Qin He*. Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy. The AAPS Journal, 2019, 21:18. IF=3.545
6. Rong Guo, Yang Long, Zhengze Lu, Miao Deng, Penghui He, Man Li*, Qin He*. Enhanced stability and efficacy of GEM-TOS prodrug by co-assembly with antimetastatic shell LMWH-TOS. Acta Pharmaceutica Sinica B 2019, in press. IF=5.808
7. Jingdong Rao, Ling Mei, Ji Liu, Xian Tang, Sheng Yin, Chunyu Xia, Jiaojie Wei, Dandan Wan, Xuhui Wang, Yashi Wang, Man Li, Zhirong Zhang, Qin He*. Size Adjustable Micelles Co-loaded Chemotherapeutic and Autophagy Inhibitor for Enhancing Cancer Treatment via Increasing Tumor Retention. Acta Biomaterialia, 2019, 89, 300-312. IF=6.638
8. Man Li, Hanbing Xie, Yingke Liu, Chunyu Xia, Xingli Cun, Yang Long, Xiaoxiao Chen, Miao Deng, Rong Guo, Zhirong Zhang, Qin He*. Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer. Journal of Controlled Release, 2019, 304, 204-215. IF=7.901.
9. Xiaoxiao Chen, Qianwen Yu, Yinke Liu, Qinglin Sheng, Kairong Shi, Yang Wang, Man Li, Zhirong Zhang, Qin He*. Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes. Acta Biomaterialia, 2019, 99, 339-349. IF=6.638
10. Xingli Cun, Jiantao Chen, Mengmeng Li, Xuan He, Xian Tang, Rong Guo, Miao Deng, Man Li*, Zhirong Zhang, Qin He*. Tumor-Associated Fibroblast-Targeted Regulation and Deep Tumor Delivery of Chemotherapeutic Drugs with a Multifunctional Size-Switchable Nanoparticle. ACS Appl. Mater. Interfaces, 2019, 11, (43), 39545-39559. IF = 8.456.
11. Dandan Wan, Yiliang Yang, Yiyao Liu, Xingli Cun, Man Li, Shanshan Xu, Wei Zhao, Yangyang Xiang, YueQiu, Qianwen Yu, Xian Tang, Zhirong Zhang, Qin He*. Sequential Depletion of Myeloid-derived Suppressor Cells and Tumor Cells with a Dual-pH-Sensitive Conjugated Micelle System for Cancer Chemoimmunotherapy. Journal of Controlled Release,2020, 317, 43-56. IF=7.901
您当前位置： 